Kieran Lamb's Library tagged → View Popular, Search in Google
"The big pharma company may regret its attempt to stop the use of Avastin instead of a more expensive drug to prevent blindness"
"Independent experts have condemned the Swiss pharmaceuticals company Novartis for trying to force the NHS to buy an expensive drug to treat patients suffering from a degenerative eye disease, rather than using a cheaper, unlicensed alternative."
A drugs giant is taking legal action to stop the Health Service using a cheap alternative to its eye disease treatment.
NHS trusts have been telling consultants to switch to Avastin from Lucentis, which is 15 times more expensive.
Doctors' belief that certain antidepressants can help to treat repetitive behaviors in children with autism may be based on biased information, according to a new review.
"French researchers say the use of ovarian stimulating drugs is associated with double the risk of a child developing leukaemia"
"Fertility drugs can more than double the chances of children born to mothers who struggle to get pregnant developing leukaemia, a study has shown."
"We are all swallowing an increasing number of pills, not just to treat disease but to cut the risk of getting a disease in the first place. Even in a time of austerity the NHS is spending nearly £12 billion on drugs and the total keeps rising."
"The pharmaceutical company Novartis is challenging the use of a cheaper alternative to its drug Lucentis for a common cause of loss of vision. "
The flagship fund set up by the Government to provide life-extending drugs for cancer sufferers is millions of pounds underspent while patients still face red tape in trying to get treatment.
"Health experts fear new national framework governing allocation of drugs could hit some more than others"
"Scientists are developing a drug that will protect asthma sufferers from life-threatening symptoms caused by the common cold."
"A drug will not be available to treat breast cancer on the NHS
after it was unclear whether it improved survival rates, a watchdog said
today."
"When Dawn Green was diagnosed with cancer four years ago, doctors delivered the crushing news there was nothing more they could do, and gave her just three months to live."
"With 7 million tranquilliser prescriptions on the NHS, the nation is at the end of its tether. What's to blame? "
"These are some of the recommendations made by Dame Janet Smith in the Shipman Inquiry along with details of what action, if any, has been taken. "
"A coroner has called for a review of the way GPs work after an inquest found that the “antiquated” methods of a family doctor, Howard Martin, contributed to the deaths of at least two patients. Here is a timeline of how the case unfolded. "
"A coroner has called for a review of the way GPs work after an inquest found that the “antiquated” methods of a family doctor, Howard Martin, contributed to the deaths of at least two patients. "
"Coroner calls for further review of standards after hearing into morphine-related deaths of Dr Howard Martin's patients"
"Thousands of patients with rare cancers are still being denied expensive end of life drugs despite guidelines designed to increase access, according to a new study. "
"Patients are being denied access to drugs for rarer cancers because the NHS treatment watchdog is acting contrary to the recommendations of a government inquiry, a report claims today.
Analysis by the Rarer Cancers Forum (RCF) suggests that the National Institute for Health and Clinical Excellence (NICE) is “failing to follow the spirit” of guidelines designed to improve access to end-of-life cancer treatments."
Selected Tags
Related Tags
Health (609)
News (609)
UHN (395)
IHN (163)
Daily Mail (159)
BBC Health News (108)
Cancer (95)
Daily (79)
Telegraph (79)
Ethics (69)
Evidence Based Practice (62)
The Times (58)
Cost-Effectiveness (58)
Rationing (46)
The Guardian (45)
Daily Telegraph (43)
Financial Management (42)
Mortality (40)
Influenza (39)
Top Contributors
Highlighter, Sticky notes, Tagging, Groups and Network: integrated suite dramatically boosting research productivity. Learn more »
Join Diigo